Jie Ma

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Atomic Force Microscopy

Dna Methylation

Bipolar Disorder

Top Venues

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics

Journal of neurochemistry

Schizophrenia bulletin

This page only lists publications with an associated author ORCID identifier.

Publications

Qi He, Ruochun Li, Nannan Zhong, Jie Ma, Fayi Nie, Rui Zhang
The role and molecular mechanisms of the early growth response 3 gene in schizophrenia. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 195 (5) (2024)
Qiao-Xia Zhang, Shan-Shan Wu, Peng-Jie Wang, Rui Zhang, Robert K Valenzuela, Shan-Shan Shang, Ting Wan, Jie Ma
Schizophrenia-Like Deficits and Impaired Glutamate/Gamma-aminobutyric acid Homeostasis in Zfp804a Conditional Knockout Mice. Schizophrenia bulletin (2024)
Qi He, Ruochun Li, Nannan Zhong, Jie Ma, Fayi Nie, Rui Zhang
The role and molecular mechanisms of the early growth response 3 gene in schizophrenia. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics (2024)
Qi He, Ruochun Li, Nannan Zhong, Jie Ma, Fayi Nie, Rui Zhang
The role and molecular mechanisms of the early growth response 3 gene in schizophrenia. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 195 (5) (2024)
Pengjie Wang, Manling Li, Aizhen Zhao, Jie Ma
Application of animal experimental models in the research of schizophrenia. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 186 (4) (2021)
Fayi Nie, Qiaoxia Zhang, Jie Ma, Pengjie Wang, Ruiying Gu, Jing Han, Rui Zhang
Schizophrenia risk candidate EGR3 is a novel transcriptional regulator of RELN and regulates neurite outgrowth via the Reelin signal pathway in vitro. Journal of neurochemistry 157 (6) (2020)